近些年,多肽类药物凭借其靶向性好、免疫原性低、开发设计速度快和生产成本更低,已经逐步走向生物制药的前沿。由于多肽药物的特性,其结合方法学与抗体、小分子等常见分子有巨大差异,百奥克形成一套独特的SPR检测方法和流程,帮助用户获得高质量的结合活性数据。
Fig. 1 Kinetics measurement on a novel peptide candidate binding to GLP-1 receptor on CM3 sensor chip(Biacore T200). Partially published under authorization of end-user.
Fig. 1 A molecule of peptide antibiotics binds to a receptor of human cell selectively on CM5 sensor chip(upside, Biacore T200), instead of another pathway target(downside). Partially published under authorization of end-user.
服务热线:400-136-0316
电 话:18210288648/许经理
邮 箱:xhn@baks.com.cn
地 址:北京亦庄经济技术开发区科创十二街8号合众思壮2C-806